glp-1 news employers Indiana is expanding access to GLP-1s — the diabetes and weight loss medications — to members of the state's Medicaid program. The expansion is part of a federal pilot to allow more company dropping glp-1 coverage 2025

regular eye exams for people with diabetes Suicidal Thoughts or Behavior : Warning : FDA is investigating reports of suicidal thoughts and behaviors in people taking GLP-1 medications Causality not established, but monitoring warranted Symptoms : New or worsening depression Thoughts of suicide or self-harm Unusual mood changes Increased anxiety or agitation Withdrawal from activities or relationships Action Required : Contact healthcare provider immediately Call 988 (Suicide and Crisis Lifeline) if experiencing suicidal thoughts Call 911 if immediate danger to self or others Inform family/friends so they can provide support and monitoring Risk Factors : History of depression or mental health conditions Previous suicidal thoughts or attempts Pulmonary Aspiration During Surgery : Risk : GLP-1 medications slow gastric emptying Stomach may contain food even after fasting During general anesthesia, stomach contents can enter lungs (aspiration) Can cause serious lung infection (aspiration pneumonia) Prevention : Inform surgeon and anesthesiologist about GLP-1 medication BEFORE any surgical procedure (even minor) Follow specific instructions about when to hold medication before surgery May need to hold medication 1 week or longer before elective surgery For emergency surgery, anesthesiologist will take special precautions Important : Don't skip informing surgical team - this is critical safety information Drug Interactions and Special Population Considerations Oral Contraceptive Effectiveness (Critical for Women of Childbearing Potential): According to FDA prescribing information: Tirzepatide (Zepbound) Specific Warning : May reduce effectiveness of oral contraceptives due to delayed gastric emptying Could result in unintended pregnancy Recommendations for Women Taking Oral Birth Control : Discuss contraception with healthcare provider BEFORE starting GLP-1 medication Consider switching to non-oral contraception methods: Intrauterine device (IUD - copper or hormonal) Contraceptive implant (Nexplanon) Contraceptive injection (Depo-Provera) Contraceptive patch Vaginal ring Permanent sterilization (if family complete) If continuing oral contraceptives, use additional barrier method (condoms) for: 4 weeks after starting GLP-1 medication 4 weeks after each dose increase Pregnancy Prevention Critical: Unintended pregnancy while taking GLP-1 medications should be avoided

Her ilata olduu gibi GLP-1 ilalarnn da baz yan etkileri olabilir

Glutathion (GSH) Intrazellulrer Nachweis in Immunzellen Glutathion (GSH) wirkt antioxidativ

By serving as an immediate treatment option that reduces addictive drive without precipitating withdrawal symptoms, GLP-1 supported initiation onto buprenorphine and naltrexone may improve success rates by making it easier for patients to reach the short-term withdrawal thresholds required to begin treatment